[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
August 5, 1961

Chloroquine in Hepatitis

Author Affiliations

435 N. Roxbury Drive, Beverly Hills, Calif.

JAMA. 1961;177(5):344. doi:10.1001/jama.1961.03040310062017

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  In the Questions and Answers section of The Journal (176:748 [May 27] 1961) Dr. Capps states that "it seems likely that there must be some invasion of the liver with ameba" because of the beneficial effect of chloroquine in hepatitis complicating infectious mononucleosis. Chloroquine and related agents such as hydroxychloroquine sulfate (Plaquenil) are being found useful in a number of situations, be it infectious mononucleosis, the collagen diseases, rheumatoid arthritis, or sarcoid. The beneficial effect is related to interaction of the drug with nucleoproteins, and—in ways not entirely clear—it may be helpful in the diverse conditions mentioned. This in no way makes it seem likely that there is an amebic hepatitis in infectious mononucleosis. Indeed, some degree of hepatitis is present in most cases of this illness.

First Page Preview View Large
First page PDF preview
First page PDF preview
×